Happily, not much sun exposure is required for many people to meet their vitamin D needs. Ten minutes of sun exposure at a UV ...

Newronika announced today that it closed a €13.6 million ($14.1 million) Series B round to support its deep brain stimulation ...

AB-1002 is an investigational gene therapy for the treatment of adults with non-ischemic cardiomyopathy and New York Heart Association (NYHA) Class III heart failure symptoms GenePHIT is a clinical ...

For people living with Type 1 Diabetes (T1D), keeping blood sugar levels in check is a constant challenge. A new clinical trial at UVA is aiming to simplify diabetes management by testing an ...

Revenue for the fourth quarter and full year 2024 was $47.5 million and $179.0 million, respectively. The MRD business, which contributed 85% of revenue in the fourth quarter and 81% of revenue in the ...

About Abelacimab Abelacimab is a novel, investigational, highly selective, fully human monoclonal antibody that binds tightly to Factor XI to block its activation and prevent the generation of the ...

Adaptive Biotechnologies (NASDAQ:ADPT – Get Free Report) will likely be issuing its quarterly earnings data after the market ...

Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...

The partnership between the US military body and the non-profit Global Coalition for Adaptive Research will examine three ...